Drug Detail:Evista (Raloxifene [ ra-lox-i-feen ])
Generic Name: Raloxifene hydrochloride 60mg
Dosage Form: tablet
Drug Class: Hormones / antineoplastics Selective estrogen receptor modulators
Drug Detail:Evista (Raloxifene [ ra-lox-i-feen ])
Generic Name: Raloxifene hydrochloride 60mg
Dosage Form: tablet
Drug Class: Hormones / antineoplastics Selective estrogen receptor modulators
The recommended dosage is one 60 mg EVISTA (raloxifene hydrochloride tablets) tablet daily, which may be administered any time of day without regard to meals [see Clinical Pharmacology (12.3)].
For the indications in risk of invasive breast cancer the optimum duration of treatment is not known [see Clinical Studies (14.3, 14.4)].
For either osteoporosis treatment or prevention, supplemental calcium and/or vitamin D should be added to the diet if daily intake is inadequate. Postmenopausal women require an average of 1500 mg/day of elemental calcium. Total daily intake of calcium above 1500 mg has not demonstrated additional bone benefits while daily intake above 2000 mg has been associated with increased risk of adverse effects, including hypercalcemia and kidney stones. The recommended intake of vitamin D is 400-800 IU daily. Patients at increased risk for vitamin D insufficiency (e.g., over the age of 70 years, nursing home bound, or chronically ill) may need additional vitamin D supplements. Patients with gastrointestinal malabsorption syndromes may require higher doses of vitamin D supplementation and measurement of 25-hydroxyvitamin D should be considered.